Clinical Program1

1. Taiho has an option to Arcus’s programs in Japan and certain other Asian territories (excluding China) over a 5-year term.2. Pending listing on clinicaltrials.gov.3. Clinical collaboration with Genentech, Member of the Roche Group.4. Pegylated liposomal doxorubicin.5. Clinical collaboration with Infinity Pharmaceuticals.

Oncology Discovery Pipeline